Research ExplorerScientific StaffKristian Reich

Prof.Dr.med. ID: 7775730

Kristian Reich

graph of relations
Affiliations

Publications

Matching-adjusted indirect comparison (MAIC) results confirmed by head-to-head trials: a case study in psoriasis

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis - Authors' reply

Research output: SCORING: Contribution to journal › Comment/debate › Research

Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Abrocitinib effect on patient-reported outcomes in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Secukinumab versus guselkumab in the complete resolution of ustekinumab-resistant psoriatic plaques: The ARROW study

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Efficacy of guselkumab in difficult-to-treat psoriasis regions: Data from VOYAGE 1 and VOYAGE 2 Asian subpopulations

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (129)